INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND IGF-BINDING PROTEIN 3 DURING THE FIRST YEAR IN TERM AND PRETERM INFANTS

被引：46

作者：

RAJARAM, S

CARLSON, SE

KOO, WWK

RANGACHARI, A

KELLY, DP

机构：

[1] UNIV TENNESSEE,DEPT PEDIAT,MEMPHIS,TN 38163

[2] UNIV TENNESSEE,DEPT OBSTET & GYNECOL,MEMPHIS,TN 38163

[3] ENDOCRINE SCI,CALABASAS,CA

来源：

PEDIATRIC RESEARCH | 1995年 / 37卷 / 05期

关键词：

D O I：

10.1203/00006450-199505000-00004

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Plasma IGF-I and IGF-binding protein 3 (IGFBP-3) were determined by radioimmunoassay in term infants (n = 51) at 0, 2, 4, 6, and 12 mo and preterm infants (n = 51) at -3 (28.4 wk postconceptional age), -2, -1.5, -1, 0, 2, 4, 6, 9, and 12 mo from expected term. The effects of gestational age at birth (term or preterm) and study age were determined by repeated measures analysis of variance and Fisher's least squares difference. In preterm infants, IGF-I increased between -3 and 2 mo from 0.75 to 10.4 nM, decreased between 2 and 9 mo to 7.3 nM, and increased again between 9 and 12 mo to 10.1 nM (p < 0.0001), whereas IGFBP-3 increased relatively little from -3 to 0 mo (14.2 to 30.2 nM, p < 0.05) and plateaued from 2 to 12 mo (49.8 to 62.3 nM). At 0 mo, IGF-I and IGFBP-3 were the same in term and preterm infants, but preterm infants had higher IGF-I from 2 through 12 mo (p < 0.05), higher IGFBP-3 at 2 and 4 mo (p < 0.05), and lower IGFBP-3 at 12 mo (p < 0.05). IGF-I and IGFBP-3 were correlated at most ages. First year IGF-I and IGFBP-3 are influenced by study age and by gestational age even after adjusting for early birth.

引用

页码：581 / 585

页数：5

共 29 条

[1]

Froesch E.R., Schmid C., Schwander J., Zapf J., Actions of insulin-like growth factors, Annu Rev Physiol, 47, pp. 443-467, (1985)

[2]

Cohick W.S., Clemmons D.R., The insulin-like growth factors, Annu Rev Physiol, 55, pp. 131-153, (1993)

[3]

Baxter R.C., Martin J.L., Binding proteins for the insulin-like growth factors: Structure, regulation and function, Prog Growth Factor Res, 1, pp. 49-68, (1989)

[4]

Conover C.A., Ronk M., Lombana F., Powell D.R., Structural and biological characterization of bovine insulin-like growth factor binding protein-3, Endocrinology, 127, pp. 2795-2803, (1990)

[5]

Elgin R.G., Busby W.H., Clemmons D.R., An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I, Proc Natl Acad Sci USA, 84, pp. 3254-3258, (1987)

[6]

Zapf J., Walter H., Froesch E.R., Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia, J Clin Invest, 68, pp. 1321-1330, (1981)

[7]

Furlanetto R.W., Underwood L.E., Van Wyk J.J., D'Ercole A.T., Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay, J Clin Invest, 60, pp. 648-657, (1977)

[8]

Gourmelen M., Le Bouc Y., Girard F., Binoux M., Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents, J Clin Endocrinol Metab, 59, pp. 1197-1203, (1984)

[9]

Merimee T.J., Zapf J., Froesch E.R., Dwarfism in the pygmy. An isolated deficiency of insulin-like growth factor I, N Engl J Med, 305, pp. 965-968, (1981)

[10]

Laron Z., Pertzelan A., Mannheimer S., Genetic pituitary dwarfism with high serum concentration of growth hormone—a new inborn error of metabolism?, Isr J Med Sci, 2, pp. 152-155, (1966)

← 1 2 3 →